AIMC Topic: Drug Discovery

Clear Filters Showing 891 to 900 of 1559 articles

Computational Method for Quantitative Comparison of Activity Landscapes on the Basis of Image Data.

Molecules (Basel, Switzerland)
Activity landscape (AL) models are used for visualizing and interpreting structure-activity relationships (SARs) in compound datasets. Therefore, ALs are designed to present chemical similarity and compound potency information in context. Different t...

A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes.

Nature communications
Chemoproteomics is a key technology to characterize the mode of action of drugs, as it directly identifies the protein targets of bioactive compounds and aids in the development of optimized small-molecule compounds. Current approaches cannot identif...

Current methods and challenges for deep learning in drug discovery.

Drug discovery today. Technologies
Driven by rapid advances in computer hardware and publicly available datasets over the past decade, deep learning has achieved tremendous success in the transformation of many computational disciplines. These novel technologies have had considerable ...

Challenge-Enabled Machine Learning to Drug-Response Prediction.

The AAPS journal
In recent decades, the advancement of computational algorithms and the availability of big data have enabled artificial intelligence (AI) to dramatically improve predictive performance in nearly all research areas. Specifically, machine learning (ML)...

Uncertainty Quantification Using Neural Networks for Molecular Property Prediction.

Journal of chemical information and modeling
Uncertainty quantification (UQ) is an important component of molecular property prediction, particularly for drug discovery applications where model predictions direct experimental design and where unanticipated imprecision wastes valuable time and r...

Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network.

Journal of medicinal chemistry
Rare neglected diseases may be neglected but are hardly rare, affecting hundreds of millions of people around the world. Here, we present a hit identification approach using AtomNet, the world's first deep convolutional neural network for structure-b...

The good, the bad, and the ugly in chemical and biological data for machine learning.

Drug discovery today. Technologies
Machine learning and artificial intelligence (ML/AI) have become important research tools in molecular medicine and chemistry. Their rise and recent success in drug discovery promises a rapid progression of development pipelines while reshaping how f...

Transfer Learning for Drug Discovery.

Journal of medicinal chemistry
The data sets available to train models for drug discovery efforts are often small. Indeed, the sparse availability of labeled data is a major barrier to artificial-intelligence-assisted drug discovery. One solution to this problem is to develop alg...

Practical considerations for active machine learning in drug discovery.

Drug discovery today. Technologies
Active machine learning enables the automated selection of the most valuable next experiments to improve predictive modelling and hasten active retrieval in drug discovery. Although a long established theoretical concept and introduced to drug discov...

Application of artificial neural networks to prediction of new substances with antimicrobial activity against Escherichia coli.

Journal of applied microbiology
AIMS: This article presents models of artificial neural networks (ANN) employed to predict the biological activity of chemical compounds based of their structure. Regression and classification models were designed to determine antimicrobial propertie...